Barry Labinger Insider Trading $EBS Emergent BioSolutions Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Barry Labinger.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Barry Labinger. Barry Labinger is Exec VP & CCO in HUMAN GENOME SCIENCES INC ($HGSI) and Exec VP, CCO & CFO in HUMAN GENOME SCIENCES INC ($HGSI) and EVP, Biosciences Div. in Emergent BioSolutions Inc. ($EBS) and President and CEO in Checkmate Pharmaceuticals, Inc. ($CMPI).
Barry Labinger in Emergent BioSolutions Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Barry Labinger: EVP, Biosciences Div.
Holdings: 25,182 shares
Current Value: $739,092
Latest Transaction: Nov 17 2015
$EBS Market Capitalization: $1.21B
$EBS Previous Close: $29.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Barry Labinger in Emergent BioSolutions Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CMPI, EBS, HGSI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 36.50 | 3,376 | 123,224 | 25,182 | 28.6 K to 25.2 K (-11.82 %) |
| Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | M | 20.94 | 10,094 | 211,368 | 0 | |
| Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | M | 20.94 | 10,095 | 211,389 | 0 | |
| Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | M | 28.09 | 9,373 | 263,288 | 0 | |
| Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Payment of Exercise | F | 35.88 | 1,671 | 59,955 | 28,558 | 30.2 K to 28.6 K (-5.53 %) |
| Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 36.00 | 10,094 | 363,384 | 30,229 | 40.3 K to 30.2 K (-25.03 %) |
| Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Buy | M | 20.94 | 10,094 | 211,368 | 40,323 | 30.2 K to 40.3 K (+33.39 %) |
| Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 35.50 | 10,095 | 358,373 | 30,229 | 40.3 K to 30.2 K (-25.03 %) |
| Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Buy | M | 20.94 | 10,095 | 211,389 | 40,324 | 30.2 K to 40.3 K (+33.40 %) |
| Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 35.50 | 9,373 | 332,742 | 30,229 | 39.6 K to 30.2 K (-23.67 %) |
| Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Buy | M | 28.09 | 9,373 | 263,288 | 39,602 | 30.2 K to 39.6 K (+31.01 %) |
| Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 35.51 | 6,564 | 233,088 | 30,229 | 36.8 K to 30.2 K (-17.84 %) |
| Mar 12 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | A | 28.99 | 21,517 | 623,778 | 21,517 | |
| Mar 12 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Payment of Exercise | F | 29.00 | 1,594 | 46,226 | 36,793 | 38.4 K to 36.8 K (-4.15 %) |
| Mar 12 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Grant | A | 0.00 | 10,762 | 0 | 38,387 | 27.6 K to 38.4 K (+38.96 %) |
Page: 1